Pfizer said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and immune responses in people aged 65 and above in a late-stage study. Awesome!
Photo Credit: Muhamad Reza Junianto
留言